Document is current
Any future updates will be listed below
-
Authors
Liu, Shu
Heumüller, Stefanie-Elisabeth
Hossinger, André
Müller, Stephan A. http://orcid.org/0000-0003-3414-307X
Buravlova, Oleksandra
Lichtenthaler, Stefan F. http://orcid.org/0000-0003-2211-2575
Denner, Philip
Vorberg, Ina M. http://orcid.org/0000-0003-0583-4015
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC 2145 SyNergy– ID 390857198)
Bundesministerium für Bildung und Forschung (CLINSPECT-M (FKZ161L0214C))
- License Information
-
More Information
Article History
Received: 21 June 2022
Accepted: 2 August 2023
First Online: 18 August 2023
Competing interests
: S.L., S.A.M., S.F.L., P.D., and I.M.V. hold pending patent applications for “HERV inhibitors for use in treating tauopathies”: “US Patent Application No. 17/640,119 based on PCT International Application No. PCT/EP2020/074809, claiming priority to “European Application No. 19195304.1”. The remaining authors declare no competing interests.
